Regenexx Is Awarded Another Patent

By /

I just came back from Cayman, and yesterday was my first day back in the Colorado office. Waiting for me there on my desk was a bright, shiny, and new patent from the US government. Even though this is one of many we have received, I thought a close-up of the seal on the document would be cool to share.

Regenexx Is VERY Different

In today’s world of the stem cell wild west, where everyone and his brother is offering some faux stem cell therapy, Regenexx has always been and will always be VERY different. As I showed you a few days ago, it’s very different in how the cells are taken and precisely placed back into the body. In addition, it’s very different in how we process the cells using our same-day lab technology.

Bone marrow concentrate is what’s used in a same-day bone marrow-based stem cell procedure. This product has been created the same way since the ’90s. You centrifuge the bone marrow aspirate, which creates a number of layers. You then take out the middle layer, known as the buffy coat, which is where the stem cells concentrate.

Simple Bedside Machines

Almost all physicians who perform bone marrow-based procedures use a simple bedside system to produce bone marrow concentrate (BMC). These are very convenient, as all the doctor or his or her assistant has to know is where to place the bone marrow aspirate (BMA) and the location of the “On” button. The downside is that each machine has to simplify what a technician does manually. This means that corners are cut. For example, the machine often has to include much more of the layers above and below the buffy coat as the size and location of this varies with patient hydration and blood density (hematocrit). Hence, what the machine produces is a much less concentrated and much less pure version of the buffy coat.

Improving On an Old Technique

We began working on an improvement for the bone marrow concentrate protocol many years ago, in 2011. We discovered techniques to isolate new sources of mesenchymal stem cells in bone marrow and soon submitted a patent, the one that was officially granted this summer. This technique also produced better clinical results when we compared our registry data from before the new procedure to after the higher-yield bone marrow processing was in place (see below).

Over the past several years, we have been granted a bevy of patents on various parts of our three-step process. This includes a patent on our inflammatory preinjection used to create a favorable environment for stem cell-mediated repair and the use of nanogram corticosteroid to push cells toward chondrogenesis. Hence, all parts of the Regenexx process are now protected by US patents.

The upshot? Regenexx is very different. From our lab-based and clinical research program to our clinical registry that tracks outcomes and complications to our patents, we invented this space and continue to record milestones, like insurance coverage. I want to thank our science team and Neven Steinmetz for her dedication in seeing these patents through the process to get many of them granted.

Get health and wellness information from a trusted source.

By submitting the form, you are agreeing that you read and consent to our Privacy Policy. We may also contact you via email, phone, and other electronic means to communicate information about our products and services. We do not sell, or share your information to third party vendors.

Category: Latest News

Leave a Reply

Your email address will not be published. Required fields are marked *

8 thoughts on “Regenexx Is Awarded Another Patent

  1. Corrine Stout

    Will having the patent help to someday get regenerative procedures covered by health insurance?

  2. Nyla Poser

    I hope there is a push for Medicare to begin covering this. Please tell there is. I just enrolled in Plan B and almost the same day started having issues with my left knee

    1. Regenexx Team

      Nyla,
      Sorry to hear about your knee! Unfortunately, it’s unlikely that a government program would cover these procedures. Please see: https://regenexx.com/blog/medical-care-system-broken/ and https://regenexx.com/blog/regenexx-acap-fixing-broken-medical-care-system/

  3. Masuma

    Congratulations Dr.Centeno and your team???? since it took 7-8 years for a patent, does it mean that other independent researchers had to test the procedure before a patent is awarded? Also, will more orthopedic specialists be encouraged to learn to offer it? I’m sure there a host of other issues involved!

  4. Matthew Campbell

    It is cool to see this. I am a patent practitioner and a patient, and it is very inspiring to be a part of something where the rubber is truly meeting the road.

  5. Barbara

    Congratulations!

  6. Jackie Adams

    Congrats Dr. C.!! I am 5 months out from my hip treatment at the Pittsburgh office and am doing better than I ever expected. Keep pushing forward on all fronts. Your efforts are immensely appreciated.

    1. Regenexx Team

      Thank you Jackie – glad to hear you’re doing so well!

Is Regenexx Right For You?

Request a free Regenexx Info Packet

REGENEXX WEBINARS

Learn about the #1 Stem Cell & Platelet Procedures for treating arthritis, common joint injuries & spine pain.

Join a Webinar

RECEIVE BLOG ARTICLES BY EMAIL

Get fresh updates and insights from Regenexx delivered straight to your inbox.

Subscribe to the Blog

CONTACT US

9035 Wadsworth Pkwy #1000
Westminster, CO 80021
888-525-3005

FOLLOW US

Copyright © Regenexx 2020. All rights reserved. | Privacy Policy

*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.

LinkedIn
Email